Explore 3 Stock Ideas & Industry Insights Download Free Report

Merger & Acquisition(M&A)

CBIZ (NYSE: CBZ), Inc. enters Merger Agreement, Shares to Convert at $55 Each

CBIZ, Inc. has solidified a merger agreement allowing for significant shareholder returns, with each outstanding share converting into cash at $55. This strategic move, announced as part of a structured merger with Viking ParentCo, indicates the board's commitment to enhancing shareholder value.

Vinay Lochav | 30 July 2026

Churchill Downs (NASDAQ: CHDN) Evaluates Strategic Alternatives for Gaming Assets

Churchill Downs Inc. is taking significant steps as it explores strategic alternatives for several of its regional gaming assets. This review comes at a time when the company's share price has experienced notable challenges, specifically a 20.9% decline in value year-to-date. The recent earnings …

Vinay Lochav | 30 July 2026

D. Boral ARC Acquisition I Corp. (NASDAQ: BCAR) Secures 62.28% Vote for Business Combination

On July 29, an extraordinary general meeting of D. Boral ARC Acquisition I Corp. was held, with 41,200,000 shares eligible to vote.

Vinay Lochav | 30 July 2026

Churchill Downs (NASDAQ:CHDN) to Reclaim Full Ownership of United Tote From NYRA

Churchill Downs Incorporated has entered into a definitive agreement to reacquire 49% of United Tote Company from NYRA Content Management Solutions, a subsidiary of the New York Racing Association, effectively unwinding a stake CDI had sold to NYRA back in April 2024. Under the …

Nitish Kishor | 30 July 2026

Johnson & Johnson (NYSE:JNJ) Expands Oncology and Immunology Pipeline With Firefly Bio Deal and Sail Biomedicines Option

Johnson & Johnson announced two separate biotechnology transactions on the same day, each aimed at strengthening a different corner of its innovative medicine pipeline. The company completed its acquisition of Firefly Bio for 1 billion dollars in cash, gaining the biotech's proprietary Firelink degrader …

Nitish Kishor | 30 July 2026

Processa Pharmaceuticals (NASDAQ:PCSA) Acquires Vidya Therapeutics, Secures $200 Million Private Placement

Processa Pharmaceuticals (NASDAQ:PCSA) has acquired Vidya Therapeutics, a clinical-stage biotechnology company developing VT-7208, a next-generation Bruton's tyrosine kinase inhibitor designed for immune-mediated diseases including food allergy, chronic spontaneous urticaria, and relapsing multiple sclerosis. The acquisition is structured as a stock-for-stock transaction, with Vidya's equity …

Nitish Kishor | 30 July 2026

IonQ and SkyWater Merger to Close on July 31

IonQ has secured final regulatory approval for its acquisition of SkyWater Technology, paving the way for a merger set to close on July 31, 2026. This strategic move positions IonQ to significantly advance its quantum computing roadmap while enhancing its domestic semiconductor supply chain. …

Vinay Lochav | 29 July 2026

DRS (NASDAQ: DRS) Secures Multi-Domain AI Edge in Q4 2026 Raft Integration

Leonardo DRS, Inc. The acquisition is intended to broaden DRS’s suite of open‑architecture mission software, tools that enable national‑security clients to better process and interpret data from a variety of sensors. By adding Raft’s expertise, DRS aims to provide customers with more streamlined decision‑making …

Vinay Lochav | 29 July 2026

Skyworks Solutions (NASDAQ: SWKS) Reports $935M Revenue, Takes Key Steps for Qorvo Merger

Skyworks Solutions, Inc. (NASDAQ: SWKS) has achieved a revenue of $935 million in its third fiscal quarter of 2026, along with a non-GAAP diluted EPS of $1.08, exceeding Wall Street's consensus estimate of $1.04. This strong financial performance not only reflects the company’s operational …

Vinay Lochav | 29 July 2026

Standard BioTools (NASDAQ: LAB) Secures $30M in Royalty Buyout From Illumina

Standard BioTools Inc. (NASDAQ: LAB) has recently completed key transactions involving a substantial $30 million payment from Illumina that waives future royalty payments. This move comes as the company seeks to stabilize its financial position ahead of its anticipated merger with Treeline Biosciences. By …

Vinay Lochav | 29 July 2026
Support

Hi! How can we help you today?

Loading…